Peter Salzmann - Sep 11, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Executive Officer, Director
Signature
/s/ Peter Salzmann
Stock symbol
IMVT
Transactions as of
Sep 11, 2021
Transactions value $
$0
Form type
4
Date filed
9/14/2021, 03:59 PM
Previous filing
Aug 4, 2021
Next filing
Jan 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +431K $0.00 431K Sep 11, 2021 Common Stock 431K $8.62 Direct F1
transaction IMVT Stock Option (right to buy) Disposed to Issuer $0 -431K -100% $0.00* 0 Sep 11, 2021 Common Stock 431K $19.01 Direct F1
transaction IMVT Stock Option (right to buy) Award $0 +465K $0.00 465K Sep 11, 2021 Common Stock 465K $8.62 Direct F2
transaction IMVT Stock Option (right to buy) Disposed to Issuer $0 -465K -100% $0.00* 0 Sep 11, 2021 Common Stock 465K $17.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F2 Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.